Navigation Links
ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™
Date:10/16/2010

IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.  ISTA expects to launch BROMDAY (formerly referred to as XiDay) prior to the end of 2010.    

"BROMDAY is the only once-daily ophthalmic nonsteroidal anti-inflammatory drug (NSAID) for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.  We believe the convenience of a once-daily eye drop will help with treatment compliance and benefit patients recovering from cataract surgery," stated Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA.  "BROMDAY is an important addition to our growing prescription eye and allergy product portfolio. Within just a few weeks, our expanded sales force will be ready to promote BROMDAY to U.S.-based ophthalmologists, along with BEPREVE®, our recently launched eye drop for the treatment of itching associated with allergic conjunctivitis.

"Since the BROMDAY approval process required additional clinical investigations beyond those conducted for the original approval of XIBROM™ 0.09%, we are seeking a three-year exclusivity period under the Drug Price Competition and Patent Term Restoration Act, commonly known as the Hatch-Waxman Act.  BROMDAY represents a significant step in extending our successful bromfenac-based product line established when we launched XIBROM, our twice-daily NSAID for use following cataract surgery, in 2005.  In addition, we are evaluating a new
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and Registration
2. ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2010 Financial Results
3. Isis Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
5. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
6. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
7. Prolong Pharmaceuticals Secures $30 Million in Funding
8. Amylin Pharmaceuticals to Webcast Third Quarter Results
9. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
10. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
11. Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... Academy of Managed Care Pharmacy (AMCP) is pleased to ... Pharmacy Claims – a resource that fulfills a ... challenge between the community and managed care pharmacy practice. ... The 21-page Model Guidelines document ...
... today that it has completed notifying customers of a ... the United States and has confirmed that 51 have ... on October 11, 2011 to address a manufacturing issue ... reports of ventilator malfunctions, failures or injuries related to ...
Cached Medicine Technology:Academy of Managed Care Pharmacy (AMCP) Releases Model Audit Guidelines for Pharmacy Claims 2Academy of Managed Care Pharmacy (AMCP) Releases Model Audit Guidelines for Pharmacy Claims 3Respironics, Inc. Completes Voluntary Recall Notification of a Limited Number of Trilogy 100 Ventilators 2
(Date:4/18/2014)... 2014) -- A group of scientists from the ... Sanders-Brown Center on Aging has found interesting new ... function in Parkinson,s disease (PD). , Published ... study, which assessed cognitive function in depressed and ... replacement therapy commonly used to treat motor symptoms ...
(Date:4/18/2014)... your worst memories? How did it make you feel? ... negative personal experience, such as how sad you were ... distress, especially when you can,t stop thinking about it. ... about the context of the memories, rather than how ... to alleviate the negative effects of these memories, a ...
(Date:4/18/2014)... discovery by Northwestern Medicine scientists could lead to potential ... in people with scleroderma. , Fibrosis, or scarring, ... of the skin and lungs can lead to serious ... concept for new therapeutic options centers on findings made ... who identified the role that a specific protein plays ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... , , , , ... ) today announced that it will release financial results for its fiscal fourth ... the markets close. Cardica,s management will host a conference call at 4:30 p.m. ... company,s business. , , Conference Call Details , ...
... , , MINNEAPOLIS, July ... leading provider of integrated employee health and productivity management solutions, will conduct ... of 2009, ended June 30, 2009. The call is scheduled for 4:30 ... Participants can dial (800) 860-2442 or (412) 858-4600 to access the conference ...
... , , , ... today announced several key enhancements to its executive management team. The ... company for further profitable expansion. , , Heather ... role, Bresch will take on additional leadership responsibilities related to the ...
... , , PALO ALTO, Calif., July 29 ... Meeting of the Society of NeuroInterventional Surgery ( www.snisonline.org ) ... guiding catheter, the Echo(TM) Distal Access Catheter. , ... the ability to enable endovascular procedures in very far-reaching vessel locations -- ...
... ... leader in LED (light emitting diode) television and motion picture lighting equipment, will be ... Sciences for its proprietary lighting systems. , ... Hollywood, CA (PRWEB) July 29, 2009 -- Litepanels, Inc., the ...
... ... prepare to take the Registered Medical Transcriptionist exam and earn their RMT credential. ... Provo, Utah (PRWEB) ... a new online training program designed to help medical transcriptionists prepare to take the ...
Cached Medicine News:Health News:Cardica to Announce Fiscal 2009 Fourth Quarter and Year End Financial Results on Thursday, August 13, 2009 2Health News:Mylan Announces Enhancements to Executive Management Team 2Health News:Mylan Announces Enhancements to Executive Management Team 3Health News:Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery 2Health News:Litepanels to Receive First-Ever Emmy Statue for Lighting Equipment Technology 2Health News:Career Step Launches New Exam Prep Course for Medical Transcription Industry Credential 2